MDMA and methamphetamine: some paradoxical negative and positive mood changes in an acute dose laboratory study
- 452 Downloads
This study investigated the acute mood effects of oral MDMA, methamphetamine, and placebo in a double-blind laboratory study.
Fifty-two healthy participants comprised abstinent recreational users of stimulant drugs, 27 female and 25 male, mean age 24.8 years. Three test sessions involved acute 100 mg oral 3.4-methylendioxymethamphetamine (MDMA), 0.42 mg/kg oral methamphetamine, and matching placebo. Drug administration was counterbalanced, testing was double-blind, and medical supervision was present throughout. Car-driving performance on a laboratory simulator was assessed after 3 and 24 h, with the findings being presented elsewhere. Positive and negative moods (PANAS self-ratings) were completed before drug administration, 3, 4.5, and 24 h later. Blood samples were taken to monitor drug plasma levels.
Following MDMA, there were no significant increases in positive moods, whereas negative moods were significantly higher than under placebo. Methamphetamine led to significant increases in both positive and negative moods. The MDMA findings contrast with the elated moods, typically noted by dance clubbers on Ecstasy. However, they are consistent with some previous laboratory findings, since a wide array of positive and negative mood changes have been demonstrated. One possible explanatory factor was the neutral environmental situation, particularly if a primary action of MDMA is to intensify ongoing psychological states. Other explanatory factors, such as dosage, gender, post-drug timing, neurohormonal aspects, and social factors, are also discussed.
In the laboratory, acute methamphetamine led to significantly higher positive moods. However, against expectations, MDMA did not generate a significant increase in positive moods.
KeywordsMDMA Ecstasy Methamphetamine Mood Environment PANAS Serotonin Dopamine
This study was funded by an Australian Research Council Grant to Professors Con Stough, Papafotiou and Vic Ogden: grant DP0772762. Professor Andy Parrott was on sabbatical at the Brain Science Institute, Swinburne University, partially funded by NIDA grant DA-14910.
- Bedi G, de Wit H (2011). Individual differences in acute responses to MDMA in humans: effects of sex and past ecstasy use. Open Addiction Journal (in press)Google Scholar
- Cohen RS (1998) The love drug: marching to the beat of ecstasy. Haworth Medical Press, New York StateGoogle Scholar
- Degenhardt L, Hall W (2009). The health and psychological effects of “ecstasy” (MDMA) use. NDARC monograph, no. 62. University of New South Wales, AustraliaGoogle Scholar
- Dumont GJ, Sweep FC, van der Steen R, Hermsen R, Donders AR, Touw DJ, van Gerven JM, Buitelaar JK, Verkes RJ (2009) Increased oxytocin concentrations and prosocial feelings in humans after ecstasy (3, 4-methylenedioxymethamphetamine) administration. Soc Neurosci 4:359–366PubMedCrossRefGoogle Scholar
- Greer G, Tolbert R (1990). The therapeutic use of MDMA. The clinical, pharmacological and neurotoxicological effects of the drug MDMA. Peroutka SJ (ed.). Kluwer, New YorkGoogle Scholar
- Greer G, Tolbert R (1986). Subjective reports of the effects of MDMA in a clinical setting. J Psychoact Drugs 18:319–327Google Scholar
- Hernández-López C, Farré M, Roset PN, Menoyo E, Pizarro N, Ortuño J, Torrens M, Camí J, de La Torre R (2002) 3, 4-Methylenedioxymethamphetamine (ecstasy) and alcohol interactions in humans: psychomotor performance, subjective effects, and pharmacokinetics. J Pharmacol Exp Ther 300:236–244PubMedCrossRefGoogle Scholar
- Iversen L (2006) Speed, ecstasy, ritalin: the science of the amphetamines. Oxford University Press, OxfordGoogle Scholar
- Parrott AC (2010) Conscious awareness versus optimistic beliefs in recreational Ecstasy/MDMA users. In: Perry E, Collerton D, LeBeau F, Ashton HE (eds) New horizons in the neuroscience of consciousness. John Benjamins Publishers, AmsterdamGoogle Scholar
- Silber BY, Croft RJ, Papafotiou K, Stough C (2006) The acute effects of d-amphetamine and methamphetamine on attention and psychomotor performance. Psychopharmacology 187(1):54–169Google Scholar